Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Thailand

GPO Offers To Make Drugs Under Compulsory Licenses

March 2008 | Company News Alert

Thailand's leading drugmaker, the Government Pharmaceutical Organisation (GPO), has offered to manufacture and distribute certain medicines listed under the country's controversial compulsory licensing scheme. However, it is BMI's view that the company is unlikely to be selected as the preferred provider. Indian rivals can make the drugs for less money and the facility the GPO intends to use is still being constructed.

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Government Boosts Generic Oseltamivir Output

Companies / Thailand Thailand is planning to extend its production of oseltamivir, the generic version of Swiss drugmaker Roche's anti-flu medicine Tamiflu. The state run Government Pharmaceutical Organisation (GPO) will...
August 2006
Thai HIV/AIDS Patients Target GSK

Companies / Thailand HIV/AIDS patients in Thailand have hit the streets in protest over news that UK-based drugmaker GlaxoSmithKline (GSK) is planning to raise the cost of one of its life-saving ARV therapies, Combid. The...
August 2006
Thailand's GPO To Establish Distribution Arm?

Companies / Thailand Thailand's state-owned Government Pharmaceutical Organisation (GPO) is considering taking over the marketing of its own pharmaceuticals and cosmetics products. Presently the, GPO is able to produce various...
June 2006
Thailand's 'Bt 30 Scheme' Comes Under Fire

Companies / Thailand Thailand's low-cost health system is facing strong criticism as hospitals face soaring debts and medical practitioners increasingly desert the sector. Under the scheme, which was introduced in 2001,...
May 2006
Pfizer Thailand Forecasting Strong 2006

Companies / Thailand The Thai division of US drug giant Pfizer is forecasting healthy sales growth this year based on the development of the domestic drug market and expansion in the private hospital sector. Last year, Thailand's...
February 2006


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS